Tag - CSE:CGN

The FDA approved Cognetivity Neurosciences’ (CSE:CGN; OTCQB:CGNSF; FWB:1UB) 510(k) submission of its Integrated Cognitive Assessment (ICA) as a Class 2 exempt medical device, clearing the way for a commercial rollout...